UK’s Revamped Clinical Trials Framework To Offer Faster Application Review Timelines Than EU
Changes Represent Biggest Overhaul In UK Clinical Trials Regulation In Over 20 Years
Executive Summary
The UK has finalized plans for delivering what it believes will be a stable and streamlined clinical trials framework following its departure from the EU. Transparency, patient involvement and diversity are high on the agenda.
You may also be interested in...
UK Trial Inclusion And Diversity Plans To Have ‘Wider Scope’ Than Those In US
The UK is developing a set of questions and supporting guidance on inclusion and diversity for sponsors to consider when they design clinical trials and clinical investigations. Sponsors will be required to consider aspects beyond participants’ race and ethnicity.
UK Trial Inclusion And Diversity Plans To Have ‘Wider Scope’ Than Those In US
The UK is developing a set of questions and supporting guidance on inclusion and diversity for sponsors to consider when they design clinical trials and clinical investigations. Sponsors will be required to consider aspects beyond participants’ race and ethnicity.
UK To Launch Notification Scheme For Low-Risk Trials
The UK regulator’s new clinical trials notification scheme will allow researchers to proceed with low-risk studies without the need for further assessment.